Anemia in Pregnancy With CKD

Margriet F.C. de Jong*, Elizabeta Nemeth, Pien Rawee, Kate Bramham, Michele F. Eisenga

*Bijbehorende auteur voor dit werk

Onderzoeksoutputpeer review

1 Citaat (Scopus)
26 Downloads (Pure)


Chronic kidney disease (CKD), anemia, and iron deficiency are global health issues affecting individuals in both high-income and low-income countries. In pregnancy, both CKD and iron deficiency anemia increase the risk of adverse maternal and neonatal outcomes, including increased maternal morbidity and mortality, stillbirth, perinatal death, preterm birth, and low birthweight. However, it is unknown to which extent iron deficiency anemia contributes to adverse outcomes in CKD pregnancy. Furthermore, little is known regarding the prevalence, pathophysiology, and treatment of iron deficiency and anemia in pregnant women with CKD. Therefore, there are many unanswered questions regarding optimal management with oral or i.v. iron and recombinant human erythropoietin (rhEPO) in these women. In this review, we present a short overview of the (patho)physiology of anemia in healthy pregnancy and in people living with CKD. We present an evaluation of the literature on iron deficiency, anemia, and nutritional deficits in pregnant women with CKD; and we evaluate current knowledge gaps. Finally, we propose research priorities regarding anemia in pregnant women with CKD.

Originele taal-2English
Aantal pagina's15
TijdschriftKidney International Reports
StatusE-pub ahead of print - 11-jan.-2024


Duik in de onderzoeksthema's van 'Anemia in Pregnancy With CKD'. Samen vormen ze een unieke vingerafdruk.

Citeer dit